Safety of Long-Term Treatment With Cabergoline on Cardiac Valve Disease in Patients With Prolactinomas

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-13-0231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Cabergoline and Cardiac Valve Disease in Prolactinoma Patients: Additional Studies During Long-Term Treatment Are Required

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2008English

Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

A Prospective Study of Cardiac Valvular Status in Patients Treated With Cabergoline for Endocrine Disease

Annales d'Endocrinologie
MedicineEndocrinologyMetabolismDiabetes
2012English

Second Attempt of Cabergoline Withdrawal in Patients With Prolactinomas After a Failed First Attempt: Is It Worthwhile?

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2015English

Cardiac Toxicity Secondary to Long Term Treatment With Chloroquine

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2001English

Disease State Changes and Safety of Long-Term Donepezil Hydrochloride Administration in Patients With Alzheimer's Disease: Japan-Great Outcome of Long-Term Trial With Donepezil (J-Gold)

Psychogeriatrics
PsychiatryGerontologyGeriatricsMental Health
2018English

Long-Term Outcome of Patients With Kawasaki Disease

Pediatric Research
Child HealthPediatricsPerinatology
2003English

Long-Term Data on Sirolimus Treatment in Patients With Lupus Nephritis

Oncotarget
Oncology
2018English

Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy